VERSACLOZ Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Versacloz, and what generic alternatives are available?
Versacloz is a drug marketed by Tasman Pharma and is included in one NDA. There is one patent protecting this drug.
This drug has six patent family members in six countries.
The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clozapine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Versacloz
A generic version of VERSACLOZ was approved as clozapine by IVAX SUB TEVA PHARMS on November 26th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VERSACLOZ?
- What are the global sales for VERSACLOZ?
- What is Average Wholesale Price for VERSACLOZ?
Summary for VERSACLOZ
| International Patents: | 6 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Patent Applications: | 5,220 |
| What excipients (inactive ingredients) are in VERSACLOZ? | VERSACLOZ excipients list |
| DailyMed Link: | VERSACLOZ at DailyMed |
Pharmacology for VERSACLOZ
| Drug Class | Atypical Antipsychotic |
US Patents and Regulatory Information for VERSACLOZ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for VERSACLOZ
See the table below for patents covering VERSACLOZ around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2005007168 | ⤷ Sign Up | |
| Canada | 2532648 | FORMULATION DE SUSPENSION STABLE DE CLOZAPINE (A STABLE CLOZAPINE SUSPENSION FORMULATION) | ⤷ Sign Up |
| Spain | 2436213 | ⤷ Sign Up | |
| European Patent Office | 1646393 | FORMULATION DE SUSPENSION STABLE DE CLOZAPINE (A STABLE CLOZAPINE SUSPENSION FORMULATION) | ⤷ Sign Up |
| New Zealand | 527142 | A stable suspension formulation | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
